These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33711896)

  • 1. Importance of addition of HPV DNA testing to the cytology based cervical cancer screening and triage of findings with p16/Ki67 immunocytochemistry staining in 35 and 45 years old women LIBUSE trial data analysis.
    Sláma J; Dvořák V; Trnková M; Skřivánek A; Hurdálková K; Ovesná P; Nováčková M
    Ceska Gynekol; 2020; 85(6):368-374. PubMed ID: 33711896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women.
    Aromseree S; Wongjumpa W; Ekalaksananan T; Temtanakitpaisan A; Kleebkaow P; Srisathaporn S; Tongchai P; Pientong C
    Asian Pac J Cancer Prev; 2022 Oct; 23(10):3405-3411. PubMed ID: 36308365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study.
    Benevolo M; Ronco G; Mancuso P; Carozzi F; De Marco L; Allia E; Bisanzi S; Rizzolo R; Gustinucci D; Del Mistro A; Frayle H; Confortini M; Viti J; Iossa A; Cesarini E; Bulletti S; Passamonti B; Gori S; Toniolo L; Bonvicini L; Venturelli F; Wentzensen N; Giorgi Rossi P;
    EBioMedicine; 2024 Jun; 104():105149. PubMed ID: 38759278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Wright TC; Behrens CM; Ranger-Moore J; Rehm S; Sharma A; Stoler MH; Ridder R
    Gynecol Oncol; 2017 Jan; 144(1):51-56. PubMed ID: 28094038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
    Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
    JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population.
    Gustinucci D; Benevolo M; Cesarini E; Mancuso P; Passamonti B; Giaimo MD; Corvetti R; Nofrini V; Bulletti S; Malaspina M; Tintori B; Giorgi Rossi P;
    Int J Cancer; 2022 Mar; 150(6):952-960. PubMed ID: 34706093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions.
    Zhang R; Ge X; You K; Guo Y; Guo H; Wang Y; Geng L
    J Obstet Gynaecol Res; 2018 Nov; 44(11):2077-2084. PubMed ID: 30094887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of p16(INK4a) /Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology.
    Allia E; Ronco G; Coccia A; Luparia P; Macrì L; Fiorito C; Maletta F; Deambrogio C; Tunesi S; De Marco L; Gillio-Tos A; Sapino A; Ghiringhello B
    Cancer Cytopathol; 2015 Apr; 123(4):212-8. PubMed ID: 25534957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual staining for p16/Ki67 is a more specific test than cytology for triage of HPV-positive women.
    Areán-Cuns C; Mercado-Gutiérrez M; Paniello-Alastruey I; Mallor-Giménez F; Córdoba-Iturriagagoitia A; Lozano-Escario M; Santamaria-Martínez M
    Virchows Arch; 2018 Nov; 473(5):599-606. PubMed ID: 30094492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population.
    Luttmer R; Dijkstra MG; Snijders PJ; Berkhof J; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; van Baal WM; Graziosi PG; Quint WG; Spruijt JW; van Dijken DK; Heideman DA; Meijer CJ
    Mod Pathol; 2016 Aug; 29(8):870-8. PubMed ID: 27150161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of p16/Ki67 immunostaining in the triage of women referred to colposcopy.
    Ordi J; Sagasta A; Munmany M; Rodríguez-Carunchio L; Torné A; del Pino M
    Cancer Cytopathol; 2014 Mar; 122(3):227-35. PubMed ID: 24757722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.
    Wentzensen N; Fetterman B; Castle PE; Schiffman M; Wood SN; Stiemerling E; Tokugawa D; Bodelon C; Poitras N; Lorey T; Kinney W
    J Natl Cancer Inst; 2015 Dec; 107(12):djv257. PubMed ID: 26376685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.
    Ikenberg H; Bergeron C; Schmidt D; Griesser H; Alameda F; Angeloni C; Bogers J; Dachez R; Denton K; Hariri J; Keller T; von Knebel Doeberitz M; Neumann HH; Puig-Tintore LM; Sideri M; Rehm S; Ridder R;
    J Natl Cancer Inst; 2013 Oct; 105(20):1550-7. PubMed ID: 24096620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of P16/Ki67 dual staining in triaging hr-HPV-positive population during cervical Cancer screening in the younger women.
    Qian QP; Zhang X; Ding B; Jiang SW; Li ZM; Ren ML; Shen Y
    Clin Chim Acta; 2018 Aug; 483():281-285. PubMed ID: 29758205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
    Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16/Ki67 dual stain triage versus cytology in primary human papillomavirus-based cervical cancer screening with limited genotyping.
    Trzeszcz M; Mazurec M; Jach R; Mazurec K; Kotkowska-Szeps I; Kania M; Wantuchowicz M; Wasowska J; Duczek-Polakiewicz M; Rozmus P; Streb J; Halon A
    J Med Virol; 2023 Nov; 95(11):e29271. PubMed ID: 38009626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining Optimal Triage Strategies for hrHPV Screen-Positive Women-An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry.
    Stanczuk GA; Baxter GJ; Currie H; Forson W; Lawrence JR; Cuschieri K; Wilson A; Patterson L; Govan L; Black J; Palmer T; Arbyn M
    Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1629-1635. PubMed ID: 28887297
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical validation of p16/Ki-67 dual-stained cytology triage of HPV-positive women: Results from the IMPACT trial.
    Wright TC; Stoler MH; Ranger-Moore J; Fang Q; Volkir P; Safaeian M; Ridder R
    Int J Cancer; 2022 Feb; 150(3):461-471. PubMed ID: 34536311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy.
    Donà MG; Vocaturo A; Giuliani M; Ronchetti L; Rollo F; Pescarmona E; Carosi M; Vocaturo G; Benevolo M
    Gynecol Oncol; 2012 Aug; 126(2):198-202. PubMed ID: 22588180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program-A Prospective Observational Study from Western Norway.
    Øvestad IT; Dalen I; Andersland MS; Vintermyr OK; Moltu P; Berland JM; Janssen EAM; Haugland HK
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.